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Abstract
Objective—Most studies of pediatric bipolar disorder (BP) combine youth who have manic
symptoms, but do not meet criteria for BP I/II, into one “not otherwise specified” (NOS) group.
Consequently, little is known about how youth with cyclothymic disorder (CycD) differ from
youth with BP NOS. The objective of this study was to determine whether youth with a research
diagnosis of CycD (RDCyc) differ from youth with operationalized BP NOS.

Author Manuscript

Method—Participants from the Course and Outcome of Bipolar Youth study were evaluated to
determine whether they met RDCyc criteria. Characteristics of RDCyc youth and BP NOS youth
were compared at baseline, and over eight-years follow-up.
Results—Of 154 youth (average age 11.96 (3.3), 42% female), 29 met RDCyc criteria. RDCyc
youth were younger (p=.04) at baseline. Over follow-up, RDCyc youth were more likely to have a
disruptive behavior disorder (p=.01), and were more likely to experience irritability (p=.03), mood
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reactivity (p=.02), and rejection sensitivity (p=.03). BP NOS youth were more likely to develop
hypomania (p=.02), or depression (p=.02), and tended to have mood episodes earlier in the eightyear follow-up period.
Limitations—RDCyc diagnoses were made retrospectively and followed stringent criteria, which
may highlight differences that, under typical clinical conditions and more vague criteria, would not
be evident.
Conclusion—There were few differences between RDCyc and BP NOS youth. However, the
ways in which the groups diverged could have implications; chronic subsyndromal mood
symptoms may portend a severe, but ultimately non-bipolar, course. Longer follow-up is necessary
to determine the trajectory and outcomes of CycD symptoms.
Keywords

Author Manuscript

bipolar disorder; cyclothymic disorder; youth; longitudinal; diagnosis
Cyclothymic disorder (CycD) is a chronic and impairing subtype of bipolar disorder (BP),
but it has been under-studied in children and adolescents (Van Meter & Youngstrom, 2012),
resulting in a poor understanding of its clinical presentation and correlates. Related, it is
rarely diagnosed clinically, though some epidemiological studies, of both youth and adults,
suggest it may be the most prevalent form of BP (Angst et al., 2003; Lewinsohn, Klein, &
Seeley, 1995; Merikangas et al., 2007).

Author Manuscript
Author Manuscript

In pediatric studies of BP, CycD is commonly combined with other presentations of BP that
do not meet criteria for BP I or II, under the label “bipolar disorder not otherwise specified”
(BP NOS). Research indicates that CycD can be reliably distinguished from other childhood
disorders and, on some measures, from BP I and II (Van Meter, Youngstrom, Demeter, &
Findling, 2012; Van Meter, Youngstrom, Youngstrom, Feeny, & Findling, 2011). However,
characteristics that differ between CycD and BP NOS have not been described. The
diagnostic criteria for CycD are defined in the DSM-5 (American Psychiatric Association,
2013), but they focus primarily on exclusions (e.g., never having met criteria for an episode
of [hypo]mania or depression, not being symptom-free for more than two months), and
require detailed reporting to determine duration. In contrast, BP NOS has loose criteria;
namely manic symptoms that cause impairment, but do not meet criteria for any of the other
BP subtypes. Understandably, when making a diagnosis, the majority of clinicians and
research investigators choose BP NOS over CycD; the criteria are easier to apply and,
because little work has been done to understand differences in etiology, prognosis, or
treatment response, the added value of the complicated CycD diagnosis is not clear. This is
not the case for other subtypes of BP; BP I indicates mania, a severe mood state that
typically requires treatment with a mood stabilizing agent (Birmaher & Brent, 2007),
whereas BP II is characterized by depression and hypomania, and may require a different
treatment approach (Diler et al., 2017).
Across BP subtypes, long-term trajectories can vary widely; in the Course and Outcome of
Bipolar Youth study (COBY; Axelson et al., 2006; Birmaher et al., 2006) those who met the
COBY operationalized criteria for BP NOS (for criteria see Method section) at baseline
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tended to follow one of three trajectories in the first five years of the study; 14% had
achieved full or partial remission, 41% still met criteria for BP NOS, and 45% experienced a
manic or depressive episode (Axelson et al., 2011). Other studies have similarly found that,
over time, some youth with subsyndromal manic symptoms will experience remission, some
will continue with the same presentation, and others will develop a manic or depressive
episode (Cicero, Epler, & Sher, 2009; Martinez & Fristad, 2013). These results demonstrate
the heterogeneous nature of the youth within the BP NOS category, but we do not know
whether one reason for this heterogeneity is the inclusion of CycD cases in the BP NOS
category.

Author Manuscript

Importantly, absence of evidence is not evidence of absence - although previous crosssectional studies have indicated similarities between BP NOS and CycD in terms of
phenomenology and impairment (Van Meter et al., 2012; Van Meter et al., 2011), little is
known about whether trajectory or treatment response differ. There is some evidence that the
difference could be meaningful; it may be that youth with BP NOS as a whole are more
impaired than youth with CycD, given that they may experience episodes of major
depression (Birmaher, Axelson, Strober, et al., 2009; Cosgrove, Roybal, & Chang, 2013; Van
Meter, Henry, & West, 2013). On the other hand, youth with CycD experience chronic
symptoms lasting at least a year. This chronicity may ultimately lead to impairment on par
with the more intense symptoms experienced by youth with other subtypes of BP (Van
Meter et al., 2017). It is also possible that this more chronic presentation portends a different
life course, such as borderline personality disorder (BPD), which shares many features with
CycD (Reich, Zanarini, & Fitzmaurice, 2011).

Author Manuscript

The goals of the present study are to: (1) examine the baseline prevalence, and new onset
cases, of youth who meet research diagnostic criteria for cyclothymic disorder (RDCyc) in
the COBY sample; (2) examine differences in baseline characteristics and outcomes
between those in the RDCyc group and those who have operationalized BP NOS (at
baseline), but never meet RDCyc criteria; and (3) determine whether diagnostic category at
baseline (RDCyc or BP NOS) predicts the likelihood that a youth will experience an episode
of depression, hypomania, or mania over the follow-up period.

Author Manuscript

We hypothesize that across the follow-up period, RDCyc youth will be less likely to
experience a mood episode than the BP NOS youth (Van Meter et al., 2017). Related, we
anticipate that youth who meet the RDCyc criteria will have less intense and/or fewer manic
and depressive symptoms than youth with BP NOS, but that the RDCyc youth will be
equally impaired due to the chronicity of their symptoms. Additionally, we expect that
RDCyc youth will differ from BP NOS youth on the following baseline characteristics:
family history of psychopathology (RDCyc will have higher prevalence of non-mood
psychiatric illness, but no difference in family history of mania or depression; Van Meter et
al., 2012; Van Meter et al., 2011) and medication (although in a previous study, there were
no statistical differences, more than twice as many youth in the BP NOS group took a mood
stabilizer, and 17% more took an antipsychotic than in the RDCyc group (Van Meter et al.,
2017), consequently we expect the RDCyc youth to be less likely to be prescribed lithium or
a mood stabilizer). We anticipate that the RDCyc and BP NOS youth will have similar age
of BP onset (Van Meter et al., 2012; Van Meter et al., 2011), rates of comorbid disorders,
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consistent with previous research on both adults and children (Van Meter et al., 2012; Van
Meter, Youngstrom, & Findling, 2012), and rates of suicidal ideation and behavior (Van
Meter et al., 2017).

Method
Participants

Author Manuscript

The methods for COBY have been described in detail previously (Axelson et al., 2006;
Birmaher et al., 2006). Youths aged 7 to 17 years 11 months with DSM-IV diagnosis of BPI,
BP II, or operationally defined BP NOS were recruited at three sites. For the present study,
only those participants who were classified as BP NOS at baseline (n=154) were included.
The operationalized criteria for BP NOS (at least two concurrent manic symptoms, three if
the primary mood state was irritable, that represented a change in functioning; symptoms
that lasted a minimum of four hours within a 24-hour period; at least four days - lifetime, not
necessarily consecutive - during which the above criteria were met) would not preclude a
diagnosis of CycD, because the criteria do not require a hypomanic episode. In contrast,
those youth who were diagnosed with BP I or II would have experienced one or more mood
episodes (mania, hypomania, and/or depression), which is an exclusion for CycD.

Author Manuscript

The operational definition of cyclothymic disorder was defined as: a score of 2, 3, or 4 on
the Longitudinal Interval Follow-Up Evaluation (LIFE)(Keller, Lavori, Friedman, & et al.,
1987) Psychiatric Status Rating (PSR) Depression scale, or a score of 3 or 4 on the PSR
Hypomania scale for at least 26 of 52 consecutive weeks (at any point in the follow-up).
This parallels the DSM criterion that “the hypomanic and depressive periods have been
present for at least half the time,” (pg. 139) during the year-long symptomatic-period.
Additionally, during the initial year-long symptomatic period, they could not have a period
of eight or more consecutive weeks without symptoms, consistent with the DSM criterion
that “individual has not been without the symptoms for more than two months at a time”(pg.
139). Both depression and hypomania had to be present for at least two weeks (not
necessarily concurrent) during the 26-week period. Symptomatic weeks could not be
preceded by an episode of hypomania, mania, or depression (based on summary report from
the diagnostic interview about episodes prior to study enrollment, or based on a PSR score
of 5 or 6 on Manic, Hypomanic, or Depression PSR scales during the follow-up period)
because this would result in a diagnosis of BP I or II.

Author Manuscript

Participants and their parent(s) were scheduled to be interviewed every six months over the
course of the follow-up. Retention through an eight-year follow-up was 75%. On average,
participants were interviewed 10.46 times (SD=4.3), over an average follow-up period of 92
months (SD=19).
Procedure
The Institutional Review Board of each study site reviewed and approved the study protocol.
Informed consent/assent was obtained from all participants and their parent(s) at baseline.
For the current study, summary scores of both participant and parent responses were used for
all analyses.
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Participants and their parents were interviewed at baseline using the Schedule for Affective
Disorders and Schizophrenia for School Age Children, Present and Lifetime Version (KSADS-PL; Kaufman et al., 1997), the Kiddie Mania Rating Scale (MRS; Axelson et al.,
2003) and the depression section of the KSADS-P (DRS), to assess for both current and
lifetime psychiatric illnesses; kappas were >.80 (Birmaher, Axelson, Goldstein, et al., 2009).
At each follow-up, the MRS and DRS were used to rate the current severity of manic and
depressive symptoms.

Author Manuscript

Treatment history at baseline was collected using the Psychotropic Treatment Record of the
LIFE (Keller et al., 1987), which indicated lifetime exposure to lithium, anti-psychotic
medications, selective serotonin reuptake inhibitor (SSRI) antidepressants, and stimulant
medications. Psychosocial treatment, including hospitalization, was assessed at baseline and
follow-up via the LIFE Psychosocial Treatment Schedule.
At baseline, and at each follow-up, the participant’s current, best past, and worst past,
functioning were evaluated using the Children’s Global Assessment Scale (C-GAS; Shaffer
et al., 1983).
The socioeconomic status (SES) of each family was assessed at baseline (Hollingshead,
1975). The parent was interviewed at baseline about his/her own psychiatric history using
the Structured Clinical Interview for DSM-IV (First, Spitzer, Gibbon, & Williams, 1995),
and completed the Family History Screen (Weissman et al., 2000) about the psychiatric
history of all of the participant’s first and second degree relatives. This study focused on
psychopathology in first-degree relatives.

Author Manuscript

Participants and parents were interviewed at each follow-up using the LIFE (Keller et al.,
1987), which includes the PSR scale. The PSR facilitates a systematic assessment of
symptoms on a week-by-week basis for the period since the last interview. The PSR has
strong reliability for both percentage of time meeting diagnostic criteria for a mood episode
(intraclass correlation [ICC] = 0.85) and for percentage of time without significant
symptoms (ICC= 0.82). Reliability for PSR mood disorder ratings over the course of COBY
have had an average Kendall’s W of 0.8. Depressive and manic symptoms were scored on a
six-point scale: scores of a 5 or 6 on the depression, manic, or hypomanic symptom scales
were considered a “full” episode, and would exclude a youth from the RDCyc group.

Author Manuscript

Suicidal thoughts were also scored on a six-point PSR scale to indicate the seriousness of the
thoughts (e.g., a 6 would indicate thoughts, plus a plan/preparations). Symptoms of anxiety
disorders were also rated on a six-point scale. Symptoms of attention-deficit/hyperactivity
disorder (ADHD), oppositional defiant disorder (ODD), conduct disorder (CD), alcohol use
disorders (abuse or dependence), and substance use disorders (abuse or dependence) were
rated on a three-point scale: 1 no symptoms, 2 subthreshold symptoms, 3 full diagnostic
criteria. A PSR score of 3 would “count” as a comorbid disorder (Yen et al., 2015).
Psychotic symptoms were also assessed; if hallucinations and/or delusions were present,
psychosis over the follow-up was noted.
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Using t-tests and chi square analyses, youth who met RDCyc criteria were compared to
youth who met operationalized BP NOS criteria on baseline characteristics (demographics,
comorbid disorders, family history of psychiatric illness, and medication use). Chi square
analysis and t-tests evaluated differences in comorbid disorders, medication use,
hospitalization, functioning, and presence of specific manic and depressive symptoms over
the follow-up.
Differences in the course of illness were also assessed; cox regression, controlling for age,
sex, and any characteristic on which the two groups were found to differ, measured whether
there were differences in the time to a manic or depressive episode. Due to the potential for
attrition to bias these results, we looked at time to the onset of a mood episode only through
an eight-year follow-up, at which point retention remained strong.

Author Manuscript

In a previous publication examining an operationalized definition of cyclothymic disorder in
youth (Van Meter et al., 2017), we applied more stringent criteria, requiring that youth be
symptomatic for 44 of 52 weeks (allowing just two months total asymptomatic) and
excluding any youth who experienced a mood episode ([hypo]manic or depressive) in the
first year following the baseline appointment. As a sensitivity analysis, we also tested youth
meeting this strict definition to the other youth in the sample.

Results

Author Manuscript

DSM CycD was assessed as a diagnostic category only at baseline; 10 youth had a lifetime
history of cyclothymic disorder, but eight of these had had an episode of [hypo]mania or
depression prior to baseline, disqualifying them from a CycD diagnosis. There were 239
youth with a lifetime diagnosis of BP NOS at baseline (five of these also had a lifetime
CycD diagnosis). Of those with a lifetime CycD diagnosis, 10% had a baseline diagnosis of
BP II, and 20% had a baseline diagnosis of BP I. Among those with a lifetime BP NOS
diagnosis (excluding those who also had a lifetime CycD diagnosis), 6% had a baseline
diagnosis of BP II, 34% had a baseline diagnosis of BP I. These rates are not statistically
different, X2(1)=0.87, p=.350. See Figure 1.

Author Manuscript

One hundred fifty-four youth were enrolled with a current diagnosis of operationalized BP
NOS (35% of the total COBY sample), 29 of these met the RDCyc criteria, due to weekly
hypomanic and depressive symptoms for at least 26 of 52 consecutive weeks and no episode
of [hypo]mania or depression prior to meeting the RDCyc criteria. Two of these youth met
criteria based on their reported symptoms from prior to the baseline appointment, the
remaining 27 met criteria at some point over the follow-up. Of these, the majority (n=18)
met criteria during the first year of follow-up.
Baseline comparisons
RDCyc youth were significantly younger (mean=10.83, SD=3.2) than the BP NOS youth
(mean=12.22, SD=3.2; p=.039) and were more likely to be Hispanic (X2=3.97, p=.046).
Youth in the RDCyc group were less likely to have a comorbid anxiety disorder at baseline
(X2=5.81, p=.016). There were no other significant differences at baseline, see Table 1.
J Affect Disord. Author manuscript; available in PMC 2019 October 01.
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Of the 154 participants, 13 did not return for any follow-up assessments, and are not
included in the comparisons. All 13 were members of the BP NOS group. As a sensitivity
analysis, youth who dropped out were compared to the other youth; prevalence of females
was the only difference (p=.034).
Across the follow-up period, the RDCyc youth reported higher average “worst” functioning,
based on the C-GAS, but there were no differences in the average “best” or “current”
functioning. There were no significant group differences in time spent with hypomanic or
depressive symptoms over the follow-up. Related, both groups were equally likely to
experience mood symptom remission (defined as eight consecutive weeks of minimal, or
non-existent, non-impairing symptoms; PSR 1 or 2). See Table 1.

Author Manuscript

Over follow-up, RDCyc youth were more likely to meet criteria for a disruptive behavior
disorder (DBD; p=.014) than the BP NOS group. There was no difference in the presence of
other comorbid disorders or in the number of youth who were hospitalized.
There were several differences in terms of specific mood symptoms in the month preceding
each follow-up assessment, as assessed by the MRS and DRS. One hundred percent of the
youth in the RDCyc group experienced accelerated speech, compared to 84% of BP NOS
youth. Similarly, labile mood (97% RDCyc, 89% BP NOS), depressed mood (97% RDCyc,
88% BP NOS), depressive irritability (100% RDCyc, 95% BP NOS), mood reactivity (100%
RDCyc, 92% BP NOS), and rejection sensitivity (97% RDCyc, 88% BP NOS) were all
more common among youth in the RDCyc group.
Onset of mood episodes

Author Manuscript

Youth with BP NOS were more likely to develop hypomania (p=.016), and major depression
(p=.024). Additionally, in cox regression analyses, controlling for age, sex, and comorbid
DBD, RDCyc was a significant predictor of longer time to a hypomanic (Wald=4.84 p=.028;
X2(1)=5.91, p=.015), manic (Wald=4.58, p=.032; X2(1)=5.23, p=.022), or depressive
episode (Wald=5.39, p=.020; X2(1)=6.01, p=.014). See Figure 2.
Alternative research diagnostic criteria

Author Manuscript

Nineteen youth met the stricter research diagnostic criteria requiring that 44 of 52 weeks be
symptomatic and that no mood episode ([hypo]manic or depressive) occur in the first year
following the baseline appointment. When these youth were compared to the others in the
sample, the results were largely consistent with the differences we found comparing the
RDCyc and BP NOS youth - as described above. The only notable exceptions were that the
strict cyclothymic group was more likely to have comorbid ADHD (p=.012, in addition to
DBD p=.054), and was less likely to be psychotic (p=.050) or to be prescribed an
antidepressant (p=.041). Furthermore, the youth in the strict cyclothymic group were less
likely to have a manic episode across the follow-up (p=.005), in addition to being less likely
to have a depressive (p<.0001) or hypomanic episode (p=.022), as we found with the RDCyc
group.
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Discussion

Author Manuscript

The purpose of this study was to apply RDCyc criteria to youth with subclinical manic
symptoms (at baseline) in the COBY study, in order to evaluate potential differences in
baseline characteristics and course of illness between the RDCyc and BP NOS youth.
Results indicate that the RDCyc criteria do identify a unique, but small, group of youth who
- although similar on most other characteristics - are less likely than BP NOS youth to
develop hypomania or depression, and for those RDCyc cases that do develop a mood
episode, it is likely to come later than in the BP NOS group. Still, it is important to note that
the “current” and “best” C-GAS scores across follow-up were equivalent between groups, so
although those youth who experienced clinical mood episodes might experience worse
functioning in the short term, both groups experienced significant impairment. This is
consistent with previous studies of CycD that have shown that youth with CycD experience
impairment on par with other BP youth (Van Meter et al., 2012; Van Meter, Youngstrom,
Youngstrom, Feeny, & Findling, 2011; Van Meter et al., 2017).

Author Manuscript

Impairment is also affected by comorbid disorders; the results indicating that the RDCyc
youth experienced higher rates of DBD than the BP NOS youth was at odds with our
hypotheses. Previous reports in the child literature have indicated higher comorbidity in BP
NOS youth relative to CycD (Van Meter et al., 2017), or no difference (Van Meter et al.,
2012; Van Meter et al., 2011). However, these other studies did not follow youth as long
(two of these studies were cross-sectional), and the present result would be consistent with
the adult literature, which suggests that people with CycD have more familial
psychopathology (not necessarily mania), which could lead to greater comorbidity, in
addition to more chronic, but less intense, mood symptoms. It is also possible that CycD is
more difficult than BP NOS to differentiate from other childhood disorders, like behavior
disorders, due to the chronic nature of the symptoms. This could result in “double counting”
symptoms and artificially-inflated rates of comorbid disorders (Carlson & Klein, 2014).
Another goal of the present study was to determine whether youth in the RDCyc group
would be more likely than BP NOS youth to experience symptom remission; multiple
studies have shown diverse trajectories for youth with subsyndromal manic symptoms (D. A.
Axelson et al., 2011; Cicero et al., 2009; Findling et al., 2013; Anna R. Van Meter et al.,
2017). Although the trajectories of the youth in the present sample were consistent with
these studies for the most part - some youth progressed to BP I or II, others continued with
subsyndromal symptoms, and some improved - the RDCyc youth were not more likely to
remit. This leaves open the question of what factors determine a youth’s course of illness.

Author Manuscript

We speculated that there might be differences evident at baseline that would help clinicians
in differentiating RDCyc youth from BP NOS youth early on. We did not find evidence of
group differences with clear clinical utility; the only variables that were significantly
different were age and lifetime history of anxiety disorder. There is some evidence that
anxiety is a precursor to bipolar disorder (Sala et al., 2010), which could make this a helpful
difference. However, over follow-up, one hundred percent of the youth in the sample
developed an anxiety disorder, suggesting that differences in the presence of anxiety are
likely to be of little utility. In addition to being younger at baseline, the RDCyc were also
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younger when their symptoms started (a medium effect of d=.39, although the p-value was .
058). These may be confounded; if the RDCyc group was younger at enrollment, it follows
that average age of onset would also be younger. However, this suggests that RDCyc youth
may experience mood symptoms at an earlier age. Although, in this sample, we did not find
differences in family history of mania, other studies have shown that a family history of
mania is related to earlier BP onset and a more pernicious course of illness (Birmaher et al.,
2010; Johnson, Andersson-Lundman, Åberg-Wistedt, & Mathé, 2000; Post et al., 2008).
This trajectory - impairing and unremitting - is consistent with the adult literature on CycD,
which describes significant impairment, poor treatment response, and unremitting symptoms
(Howland & Thase, 1993; Giulio Perugi, Hantouche, Vannucchi, & Pinto, 2015; Van Meter
et al., 2012).

Author Manuscript
Author Manuscript

It was surprising that the number of weeks spent hypomanic or depressed was consistent
across the two groups. Although the majority (79%) of youth in the BP NOS group
experienced a mood episode over the course of follow-up, disqualifying them from the
RDCyc diagnosis, many also experienced chronic mood symptoms consistent with a
cyclothymic presentation. Previous work has shown that youth in the COBY BP NOS group
spend a high number of days ill (Birmaher, Axelson, Goldstein, et al., 2009), suggesting that
subsyndromal symptoms may be chronic by nature. Some have speculated that this is due to
poorer treatment response, relative to BP I, among youth with subsyndromal subtypes of BP
(Birmaher, Axelson, Goldstein, et al., 2009; Birmaher et al., 2006). It is also interesting to
note that although the research diagnostic criteria we used were fairly lenient, requiring only
26 of 52 weeks symptomatic, the majority of the RDCyc youth had cyclothymic episodes
that exceeded the stricter criterion of 44 weeks. Related, when we compared the youth
meeting the strict diagnostic definition (44+ weeks, no mood episode year one) to the rest of
the sample, our results were mostly consistent with what we found when comparing the
RDCyc group to the rest of the sample.

Author Manuscript

We hypothesized that the RDCyc youth would be less likely to be treated with anti-manic
agents, including lithium, but this was not the case. RDCyc and BP NOS youth were equally
likely to have a manic episode, and spent a similar amount of time hypomanic, so perhaps
the lack of difference in treatment for mania should not be surprising. However, RDCyc
youth were less likely to have a hypomanic episode over the follow-up (i.e., the proportion
of youth who had a [hypo]manic episode was higher in the BP NOS group), suggesting that
treatment may be guided as much by impairment as by the intensity of the symptoms.
Another factor may be that anti-manic agents are often prescribed to help with other
symptoms, such as irritability and tantrums (Pringsheim, Panagiotopoulos, Davidson, & Ho,
2011; Scotto Rosato et al., 2012), which could increase the number of prescriptions among
RDCyc youth who have high rates of comorbid DBD. It was unexpected that although both
groups spent more days depressed than hypomanic, more youth were prescribed lithium or
an atypical antipsychotic than an antidepressant. Though this may be evidence of the
effectiveness of anti-manic agents - particularly relative to the sparse data on the
effectiveness of antidepressants for bipolar depression (Goldsmith, Singh, & Chang, 2011) it may also be indicative of concern about antidepressant-coincident mania. Although
evidence that antidepressant use plays a causal role in the onset of mania is minimal (Joseph,
Youngstrom, & Soares, 2009) and treatment guidelines include the use of antidepressants (in
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conjunction with a mood stabilizer)(Kowatch et al., 2005), clinicians may be reluctant to use
this class of medication.

Author Manuscript

The result that the RDCyc group reported more intense depressive irritability was consistent
with research on both adults and children with CycD showing that irritability is a key
characteristic of the illness (Akiskal, Djenderedjian, Rosenthal, & Khani, 1977; Hantouche
& Perugi, 2012; Prakash & Mitra, 2008; Shen, Alloy, Abramson, & Sylvia, 2008; Van Meter
et al., 2016; Van Meter et al., 2012). Related, the fact that rejection sensitivity was more
common in the RDCyc group is consistent with evidence suggesting that people with CycD
struggle interpersonally. Another - perhaps more controversial - interpretation of this finding
could be that these youth are more likely to have a presentation consistent with BPD, rather
than (or in addition to) BP. There has been speculation that BPD and BP exist on a
continuum, and that the differences between the disorders are more theoretical (e.g., etiology
of the illness) than clinical (Perugi, 2006; Giulio Perugi et al., 2015). Although historically,
personality disorders have been diagnosed only in adults, the validity of the diagnosis in
youth is gaining support (Miller, Muehlenkamp, & Jacobson, 2008; Winsper et al., 2016). In
a previous paper, the presence of BPD in a subset of the COBY sample was examined (Yen
et al., 2015); the results suggested that although BPD was fairly prevalent (12%), it was not
more likely among any particular subtype of BP (I, II or NOS). When baseline
characteristics were compared between the BPD+ and the BPD- groups, only internalizing
symptoms (depression and anxiety) varied. In our study, we found inconsistent differences in
internalizing symptoms between RDCyc and BP NOS, limiting the degree to which we can
predict differences in in the prevalence of BPD between the RDCyc+ and RDCyc- groups.
Related, in the COBY BPD paper, suicidal and self-injurious behaviors were higher in the
BPD+ group, but we found no difference in these outcomes in our two groups. Further
exploring the prevalence of BPD among young people is important, and even more crucial is
investigating, longitudinally, whether some youth with subclinical manic symptoms meet
criteria for BPD as the grow up, but never meet criteria for a [hypo]manic or depressive
episode. This could help us to understand whether childhood mood lability is a risk factor
for BPD, or an early expression of the illness. CycD and BPD are currently conceptualized
as similar, but separate, illnesses with different expected outcomes and treatment strategies;
gaining a better understanding of the etiology and early course of each is important to
informing this conceptualization and future research.

Author Manuscript
Limitations

Author Manuscript

Although the COBY sample offers a unique opportunity to study differences in CycD and
BP NOS, there are some limitations. First, because the diagnosis of CycD was not included
in the diagnostic categories assigned following the baseline appointment, the RDCyc
diagnoses were based on symptom reports. The level of detail recorded supports this
approach, but the BP NOS diagnoses and RDCyc diagnoses were not made with the same
process. Related, the BP NOS criteria used in COBY are operationalized, whereas DSM-IV
criteria are not. This - particularly in combination with the operationalized cyclothymic
disorder criteria - may highlight differences that, under typical clinical conditions and more
vague criteria, would not be evident. The conclusions we can draw are also limited by the
small number of people who met the RDCyc criteria; it is possible that we did not have
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adequate power to capture the effects that we were looking for, but as one of only two
longitudinal studies (both secondary analyses) attempting to explore the course of
cyclothymic disorder in youth, we believe these results can inform future studies designed to
answer questions related to the phenomenology and course of youth with cyclothymic
disorder, and how the disorder compares to other bipolar subtypes. Additionally, COBY is a
naturalistic study and medication use was not controlled; however, there were no medication
differences noted in follow-up treatment between the groups.

Author Manuscript

A primary aim of the study was to determine whether BP NOS youth would be more likely
to develop mania or depression; although the participants were followed, on average, for
more than seven years, it is possible that some will still develop mania or depression.
Related, there were more participants in the BP NOS group who dropped out. Though it is
possible that these youth dropped out because they were more ill (or some other clinical
reason), there were no meaningful differences at baseline to suggest this. Finally,
participants were recruited from three academic medical centers and were predominantly
White, which may limit the generalizability of the results. Nevertheless, course and
morbidity in non-clinically referred BP youth have been shown to be similar to those among
referred populations (Lewinsohn et al., 1995).

Conclusion

Author Manuscript

The RDCyc criteria identified youth who, although similar to the BP NOS youth at baseline,
showed a distinct trajectory less likely to result in a hypomanic or depressive episode.
Additionally, the RDCyc youth were more likely to experience irritability, mood reactivity,
and rejection sensitivity over the follow-up, raising questions about whether these youth
might be at risk for developing BPD. To date, no study has followed youth with CycD into
adulthood; continuing to follow participants in COBY, along with other longitudinal cohorts
(Van Meter et al., 2017) and new samples of youth with subsyndromal mania, will help to
clarify the long-term prognosis for these youth.
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Figure 1.

Model of diagnostic categorization
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Cox regression plots indicating the difference in the duration of symptoms, following
baseline, prior to the onset of a hypomanic, manic, or depressive episode, respectively, for
Bipolar Disorder Not Otherwise Specified (BP NOS) and Research Diagnosis of
Cyclothymic Disorder (RDCyc). Note: Analyses control for age, sex, and disruptive
behavior disorder diagnosis.

Author Manuscript
Author Manuscript
J Affect Disord. Author manuscript; available in PMC 2019 October 01.

Van Meter et al.

Page 17

Table 1.

Author Manuscript

Characteristics of Research Diagnostic Cyclothymic Disorder (RDCyc) and Operationalized Bipolar Disorder
Not Otherwise Specified (BP NOS)
RDCyc

BP NOS

n=29

n=125

Cohen’s d

Mean (SD)

Characteristics at Baseline

Author Manuscript

SES (Hollingshead Four Factor Index)

3.45(1.2)

3.45(1.1)

0

Age

10.83(3.2)

12.22(3.2)

−0.43*

Age at illness onset

7.60(3.7)

9.02(3.6)

−0.39

Duration of illness

3.53(2.05)

4.26(3.0)

−0.29

C-GAS Score

56.45(8.39)

57.08(11.6)

−0.06

3.31(1.5)

3.71(1.7)

−0.25

Number of Comorbid Disorders

W

Percent

Author Manuscript

1st

Percent female

45

41

0.03

Percent White

79

83

0.04

Percent Hispanic

10

2

0.16

Lifetime history of suicidal ideation

66

73

0.06

Lifetime history of suicide attempt

10

23

0.12

Lifetime history of self injury

21

34

0.12

Lifetime history of ADHD

72

59

0.11

Lifetime history of anxiety disorder

24

49

0.19*

Lifetime history of ODD or CD

48

50

0.01

Lifetime history of Psychosis

17

11

0.07

Lifetime history of alcohol use disorder

3

5

0.03

Lifetime history of substance use disorder

3

10

0.09

1st degree relative history of mania

28

28

0.02

1st degree relative history of depression

66

72

0.09

degree relative history of non-mood psychopathology

79

80

0.01

Any current medication

97

83

0.15

Author Manuscript

Lithium

10

14

0.04

Atypical antipsychotic

41

34

0.06

SSRI anti-depressant

17

26

0.08

Stimulant

41

26

0.13

n=29

n=112

Characteristics across Follow-up

Mean (SD)

Cohen’s d

Average “worst” C-GAS

52.41(7.1)

46.15(8.9)

0.78**

Average “best” C-GAS

64.70(7.0)

64.28(9.1)

0.05
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RDCyc

BP NOS

62.38(7.6)

60.47(8.7)

0.23

Total weeks depressed

191.00(97.5)

164.94(112.8)

0.25

Total weeks hypomanic

120.97(80.0)

117.39(96.2)

0.04

Average “current” C-GAS

W

Percent
Hypomanic episode

24

49

0.20*

Manic episode

24

26

0.02

Depressive episode

48

71

0.19*

Remitted at some point

90

79

0.11

Suicidal ideation

93

95

0.03

Suicide attempt

7

26

0.02

Author Manuscript

Comorbid ADHD

83

67

0.14

Comorbid anxiety

100

100

-

ODD or CD

83

58

0.21*

Psychosis

3

13

0.13

Alcohol use disorder

10

21

0.10

Substance use disorder

0

0

-

Lithium

21

28

0.06

Atypical antipsychotic

48

47

0.01

SSRI anti-depressant

24

34

0.09

Stimulant

48

37

0.10

Hospitalization

24

31

0.06

*

p<.05

Author Manuscript

a

Defined as a PSR score of 3 or 4 on the Hypomania scale

b

Defined as a PSR score of 2, 3, or 4 on the Depression scale

SES = Socioeconomic Status; C-GAS = Children’s Global Assessment Scale; ADHD = Attention Deficit Hyperactivity Disorder; ODD =
Oppositional Defiant Disorder; CD = Conduct Disorder; SSRI = Serotonin Selective Reuptake Inhibitor
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